Comparison of four antimicrobial susceptibility testing methods to determine the in vitro activities of piperacillin and piperacillin-tazobactam against clinical isolates of Enterobacteriaceae and Pseudomonas aeruginosaKARLOWSKY, James A; WEAVER, Mellany K; THORNSBERRY, Clyde et al.Journal of clinical microbiology (Print). 2003, Vol 41, Num 7, pp 3339-3343, issn 0095-1137, 5 p.Article

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: Results from the Trust Surveillance Program (1998-2002)KARLOWSKY, James A; THORNSBERRY, Clyde; JONES, Mark E et al.Clinical infectious diseases. 2003, Vol 36, Num 8, pp 963-970, issn 1058-4838, 8 p.Article

Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001KARLOWSKY, James A; DRAGHI, Deborah C; JONES, Mark E et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1681-1688, issn 0066-4804, 8 p.Article

Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaximeKARLOWSKY, James A; JONES, Mark E; DRAGHI, Deborah C et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 10, pp 3155-3160, issn 0066-4804, 6 p.Article

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United StatesKARLOWSKY, James A; KELLY, Laurie J; THORNSBERRY, Clyde et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 8, pp 2540-2545, issn 0066-4804Article

Differences Between Ceftriaxone and Cefotaxime : Microbiological InconsistenciesGUMS, John G; WESSTON BOATWRIGHT, D; CAMBLIN, Mark et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 1, pp 71-79, issn 1060-0280, 9 p.Article

Baseline study to determine in vitro activities of daptomycin against Gram-positive pathogens isolated in the United States in 2000-2001CRITCHLEY, Ian A; BLOSSER-MIDDLETON, Renée S; JONES, Mark E et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1689-1693, issn 0066-4804, 5 p.Article

Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: Results from 2000-2001 and 2001-2002 TRUST studies in the United StatesKARLOWSKY, James A; THORNSBERRY, Clyde; CRITCHLEY, Ian A et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 6, pp 1790-1797, issn 0066-4804, 8 p.Article

Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue infections: United States LIBRA surveillance data from 1999CRITCHLEY, Ian A; SAHM, Daniel F; THORNSBERRY, Clyde et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 2, pp 129-135, issn 0732-8893Article

Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United StatesKARLOWSKY, James A; KELLY, Laurie J; THORNSBERRY, Clyde et al.International journal of antimicrobial agents. 2002, Vol 19, Num 1, pp 21-31, issn 0924-8579Article

Stable antimicrobial susceptibility rates for clinical isolates of Pseudomonas aeruginosa from the 2001-2003 tracking resistance in the United States today surveillance studiesKARLOWSKY, James A; JONES, Mark E; THORNSBERRY, Clyde et al.Clinical infectious diseases. 2005, Vol 40, pp S89-S98, issn 1058-4838, SUP2Article

Activities of faropenem, an oral β-lactam, against recent U.S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalisCRITCHLEY, Ian A; KARLOWSKY, James A; DRAGHI, Deborah C et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 2, pp 550-555, issn 0066-4804Article

In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IVJONES, Mark E; CRITCHLEY, Ian A; KARLOWSKY, James A et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 6, pp 1651-1657, issn 0066-4804Article

In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditorenKARLOWSKY, James A; JONES, Mark E; DRAGHI, Deborah C et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 1, pp 59-64, issn 0732-8893Article

The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000JONES, Mark E; BLOSSER-MIDDLETON, Renee S; CRITCHLEY, Ian A et al.Chemotherapy (Basel). 2002, Vol 48, Num 5, pp 232-237, issn 0009-3157, 6 p.Article

Extraction of small boat harmonic signatures from passive sonarOGDEN, George L; ZURK, Lisa M; JONES, Mark E et al.The Journal of the Acoustical Society of America. 2011, Vol 129, Num 6, pp 3768-3776, issn 0001-4966, 9 p.Article

Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002FLAMM, Robert K; WEAVER, Mellany K; THORNSBERRY, Clyde et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 7, pp 2431-2436, issn 0066-4804, 6 p.Article

Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001CRITCHLEY, Ian A; DRAGHI, Deborah C; SAHM, Daniel F et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 51, Num 3, pp 639-649, issn 0305-7453, 11 p.Article

Apparent plateau in β-lactamase production among clinical isolates of Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the LIBRA Surveillance initiativeJONES, Mark E; KARLOWSKY, James A; BLOSSER-MIDDLETON, Renée et al.International journal of antimicrobial agents. 2002, Vol 19, Num 2, pp 119-123, issn 0924-8579Article

Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the USKARLOWSKY, James A; DRAGHI, Deborah C; THORNSBERRY, Clyde et al.International journal of antimicrobial agents. 2002, Vol 20, Num 2, pp 76-85, issn 0924-8579, 10 p.Article

Prevalence of molecular types and mecA gene carriage of coagulase-negative staphylococci in a neonatal intensive care unit: Relation to nosocomial septicemiaKREDIET, Tannette G; JONES, Mark E; JANSSEN, Karin et al.Journal of clinical microbiology (Print). 2001, Vol 39, Num 9, pp 3376-3378, issn 0095-1137Article

Reactor Scale-up for Fluidized Bed Conversion of Ethane to Vinyl ChlorideHICKMAN, Daniel A; JONES, Mark E; JOVANOVIC, Zoran R et al.Industrial & engineering chemistry research. 2010, Vol 49, Num 21, pp 10674-10681, issn 0888-5885, 8 p.Conference Paper

Antibiotic susceptibility of bacteria most commonly isolated from bone related infections: the role of cephalosporins in antimicrobial therapyJONES, Mark E; KARLOWSKY, James A; DRAGHI, Deborah C et al.International journal of antimicrobial agents. 2004, Vol 23, Num 3, pp 240-246, issn 0924-8579, 7 p.Article

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapyJONES, Mark E; KARLOWSKY, James A; DRAGHI, Deborah C et al.International journal of antimicrobial agents. 2003, Vol 22, Num 4, pp 406-419, issn 0924-8579, 14 p.Article

Activity of cefditoren against β-lactamase-positive and -negative Haemophilus influenzae and Moraxella catarrhalisKARLOWSKY, James A; CRITCHLEY, Ian A; DRAGHI, Deborah C et al.Diagnostic microbiology and infectious disease. 2002, Vol 42, Num 1, pp 53-58, issn 0732-8893Article